Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Current Microbiology|October 9, 2024
Invasive Fungal Infections in Immunocompromised Conditions: Emphasis on COVID-19Mahaldeep Kaur, Payal Thakur, Nandini Verma, et al.
Cell Death & Disease|September 26, 2018
PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ proteinAmir Kedan, Nandini Verma, Ashish Saroha, et al.
Cancer Causes & Control : CCC|April 28, 2021
Symposium report: breast cancer in India-trends, environmental exposures and clinical implicationsJasmine A McDonald, Roshni Rao, Marley Gibbons, et al.
Science Advances|September 16, 2020
Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosisNandini Verma, Yaron Vinik, Ashish Saroha, et al.
Cancer Research|October 30, 2016
Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 AxisNandini Verma, Anna-Katharina Müller, Charu Kothari, et al.
Advances in Cancer Research|June 29, 2020
HER family in cancer progression: From discovery to 2020 and beyondRakesh Kumar, Bijesh George, Marcia R Campbell, et al.
Cancer Cell International|February 19, 2025
EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKINazia Chaudhary, Bhagya Shree Choudhary, Anusha Shivashankar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2025
Patient-Derived Organoids and Xenografts Uncover Therapeutic Vulnerabilities in Colorectal Signet Ring Cell CarcinomasNazia Chaudhary, Alessandro La Ferlita, Bhagya Shree Choudhary, et al.
Redox Biology|December 20, 2024
Inhibiting de novo lipogenesis identifies a therapeutic vulnerability in therapy-resistant colorectal cancerEeshrita Jog, Ashwin Kumar Jainarayanan, Alessandro La Ferlita, et al.
Redox Biology|September 19, 2025
Low-GPX4 drives a sustained drug-tolerant persister state in TNBC by a targetable adaptive FSP1 upregulationNazia Chaudhary, Dibita Mandal, Bhagya Shree Choudhary, et al.
Pageof 2